319 related articles for article (PubMed ID: 33093777)
21. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.
Kampolis CF; Fragkioudaki S; Mavragani CP; Zormpala A; Samakovli A; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):94-101. PubMed ID: 29846161
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
He C; Chen Z; Liu S; Chen H; Zhang F
Int J Rheum Dis; 2020 Aug; 23(8):1009-1018. PubMed ID: 32588976
[TBL] [Abstract][Full Text] [Related]
23. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
Fischer A; Brown KK; Du Bois RM; Frankel SK; Cosgrove GP; Fernandez-Perez ER; Huie TJ; Krishnamoorthy M; Meehan RT; Olson AL; Solomon JJ; Swigris JJ
J Rheumatol; 2013 May; 40(5):640-6. PubMed ID: 23457378
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary manifestations of Sjögren's syndrome.
Flament T; Bigot A; Chaigne B; Henique H; Diot E; Marchand-Adam S
Eur Respir Rev; 2016 Jun; 25(140):110-23. PubMed ID: 27246587
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study.
Panopoulos ST; Bournia VK; Trakada G; Giavri I; Kostopoulos C; Sfikakis PP
Lung; 2013 Oct; 191(5):483-9. PubMed ID: 23925736
[TBL] [Abstract][Full Text] [Related]
31. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
32. Respiratory infection risk in primary Sjögren's syndrome complicated with interstitial lung disease: a retrospective study.
Zhou X; Li H; Wang N; Jin Y; He J
Clin Rheumatol; 2024 Feb; 43(2):707-715. PubMed ID: 38091126
[TBL] [Abstract][Full Text] [Related]
33. [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease].
Mo HY; Wang LF; Xu J; Shi YH; Yang M; Zhou RH
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):495-9. PubMed ID: 22041773
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
35. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
[TBL] [Abstract][Full Text] [Related]
36. Serum bilirubin levels in primary Sjögren's syndrome: an association with interstitial lung disease.
Peng YF; Lu FY; Ma LY
BMC Pulm Med; 2023 Sep; 23(1):366. PubMed ID: 37777728
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis.
Lombardi F; Stewart I; Fabbri L; Adams W; Kawano-Dourado L; Ryerson CJ; Jenkins G;
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413120
[TBL] [Abstract][Full Text] [Related]
38. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome.
Lee KA; Nam BD; Hwang JH; Kim HS
Sci Rep; 2023 Jun; 13(1):9189. PubMed ID: 37280251
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.
Gupta S; Ferrada MA; Hasni SA
Front Immunol; 2019; 10():1327. PubMed ID: 31249572
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
Dong X; Gao YL; Lu Y; Zheng Y
Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
